KRINGLE PHARMA

Kringle Pharma, Inc., a biopharmaceutical company, develops pharmaceutical products based on its research on hepatocyte growth factor (HGF) and NK4. Its HGF has the regenerative healing ability in regard to liver cells, as well as various cells and organs; and NK4 is a bi-functional molecule, which inhibits the invasion and metastasis of tumor cells as an HGF-antagonist, as well as possesses antiangiogenic activity. The company’s pipeline includes recombinant human HGF for the treatment of acute renal failure, skin ulcers, and CNS diseases; and recombinant human NK4 and NK4 gene drugs for cancer therapy. Kringle Pharma, Inc. was founded in 2001 and is based in Toyonaka, Japan.

#SimilarOrganizations #People #Financial #Website #More

KRINGLE PHARMA

Industry:

Biotechnology Medical Nursing And Residential Care Pharmaceutical

Founded:

2001-12-21

Address:

Toyonaka, Osaka, Japan

Country:

Japan

Website Url:

http://www.kringle-pharma.com

Total Employee:

11+

Status:

Active

Contact:

81 6 6831 3330

Email Addresses:

[email protected]

Total Funding:

36.19 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics

Similar Organizations

arbutus-biopharma-logo

Arbutus Biopharma

Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.

ascentage-pharma-logo

Ascentage Pharma

Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company.

frontier-biotechnologies-logo

Frontier Biotechnologies

Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.

intrabio-logo

IntraBio

IntraBio is a biopharmaceutical company.

Current Employees Featured

not_available_image

Kunio Matsumoto
Kunio Matsumoto Chief Scientific Officer and Director @ Kringle Pharma
Chief Scientific Officer and Director

not_available_image

Keigo Hanada
Keigo Hanada Director Pharmaceutical Development Division @ Kringle Pharma
Director Pharmaceutical Development Division

tomoya-shimojo_image

Tomoya Shimojo
Tomoya Shimojo CFO @ Kringle Pharma
CFO

not_available_image

Kunio Iwatani
Kunio Iwatani President and CEO @ Kringle Pharma
President and CEO

not_available_image

Kiichi Adachi
Kiichi Adachi Chief Executive Officer, President and Director @ Kringle Pharma
Chief Executive Officer, President and Director

Founder

not_available_image

Kunio Matsumoto

Investors List

maruishi-pharmaceutical-co-ltd_image

Maruishi Pharmaceutical Co. Ltd.

Maruishi Pharmaceutical Co. Ltd. investment in Corporate Round - Kringle Pharma

ogaki-kyoritsu-bank_image

Ogaki Kyoritsu Bank

Ogaki Kyoritsu Bank investment in Venture Round - Kringle Pharma

resona-capital_image

Resona Capital

Resona Capital investment in Venture Round - Kringle Pharma

osaka-university-venture-capital_image

Osaka University Venture Capital

Osaka University Venture Capital investment in Venture Round - Kringle Pharma

miraca-holdings_image

Miraca Holdings

Miraca Holdings investment in Venture Round - Kringle Pharma

chishima-real-estate_image

Chishima Real Estate

Chishima Real Estate investment in Venture Round - Kringle Pharma

yitu-capital_image

Yitu Capital

Yitu Capital investment in Venture Round - Kringle Pharma

nanto-bank_image

Nanto Bank

Nanto Bank investment in Venture Round - Kringle Pharma

venture-labo-investment-co-ltd_image

Venture Labo Investment

Venture Labo Investment investment in Venture Round - Kringle Pharma

ht-capital-5afe_image

HT Capital

HT Capital investment in Venture Round - Kringle Pharma

Official Site Inspections

http://www.kringle-pharma.com Semrush global rank: 5.35 M Semrush visits lastest month: 1.56 K

Host Informations
Whois Informations

Loading ...

More informations about "Kringle Pharma" on Search Engine